| Novel markers to delineate murine M1 and M2 macrophages KA Jablonski, SA Amici, LM Webb, JD Ruiz-Rosado, PG Popovich, ... PloS one 10 (12), e0145342, 2015 | 989 | 2015 |
| Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity M Guerau-de-Arellano, KM Smith, J Godlewski, Y Liu, R Winger, ... Brain 134 (12), 3578-3589, 2011 | 242 | 2011 |
| miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis KM Smith, M Guerau-de-Arellano, S Costinean, JL Williams, A Bottoni, ... The Journal of Immunology 189 (4), 1567-1576, 2012 | 213 | 2012 |
| Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor κB (NF-κB) and extracellular signal-regulated kinase 1 and 2 (ERK1/2) and mitogen stress-activated … H Peng, M Guerau-de-Arellano, VB Mehta, Y Yang, DJ Huss, ... Journal of Biological Chemistry 287 (33), 28017-28026, 2012 | 213 | 2012 |
| Neonatal tolerance revisited: a perinatal window for Aire control of autoimmunity M Guerau-de-Arellano, M Martinic, C Benoist, D Mathis Journal of Experimental Medicine 206 (6), 1245-1252, 2009 | 201 | 2009 |
| Molecular mechanisms modulating the phenotype of macrophages and microglia SA Amici, J Dong, M Guerau-de-Arellano Frontiers in immunology 8, 303985, 2017 | 184 | 2017 |
| CD38 is robustly induced in human macrophages and monocytes in inflammatory conditions SA Amici, NA Young, J Narvaez-Miranda, KA Jablonski, J Arcos, L Rosas, ... Frontiers in immunology 9, 1593, 2018 | 179 | 2018 |
| Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction T Wang, JNR Gnanaprakasam, X Chen, S Kang, X Xu, H Sun, L Liu, ... Nature metabolism 2 (7), 635-647, 2020 | 176 | 2020 |
| CD38: an immunomodulatory molecule in inflammation and autoimmunity ZL Piedra-Quintero, Z Wilson, P Nava, M Guerau-de-Arellano Frontiers in immunology 11, 597959, 2020 | 169 | 2020 |
| Control of the inflammatory macrophage transcriptional signature by miR-155 KA Jablonski, AD Gaudet, SA Amici, PG Popovich, M Guerau-de-Arellano PloS one 11 (7), e0159724, 2016 | 141 | 2016 |
| miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing M Guerau-de-Arellano, H Alder, HG Ozer, A Lovett-Racke, MK Racke Journal of neuroimmunology 248 (1-2), 32-39, 2012 | 107 | 2012 |
| Increased micro-RNA 29b in the aged brain correlates with the reduction of insulin-like growth factor-1 and fractalkine ligand AM Fenn, KM Smith, AE Lovett-Racke, M Guerau-de-Arellano, ... Neurobiology of aging 34 (12), 2748-2758, 2013 | 103 | 2013 |
| miR-155 deletion in mice overcomes neuron-intrinsic and neuron-extrinsic barriers to spinal cord repair AD Gaudet, S Mandrekar-Colucci, JCE Hall, DR Sweet, PJ Schmitt, X Xu, ... Journal of Neuroscience 36 (32), 8516-8532, 2016 | 92 | 2016 |
| Treatment of experimental autoimmune encephalomyelitis by codelivery of disease associated Peptide and dexamethasone in acetalated dextran microparticles KJ Peine, M Guerau-de-Arellano, P Lee, N Kanthamneni, M Severin, ... Molecular pharmaceutics 11 (3), 828-835, 2014 | 76 | 2014 |
| Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse R Maron, M Guerau-De-Arellano, X Zhang, HL Weiner Journal of autoimmunity 16 (1), 21-28, 2001 | 76 | 2001 |
| TGF‐β signaling via Smad4 drives IL‐10 production in effector Th1 cells and reduces T‐cell trafficking in EAE DJ Huss, RC Winger, GM Cox, M Guerau‐de‐Arellano, Y Yang, ... European journal of immunology 41 (10), 2987-2996, 2011 | 72 | 2011 |
| PRMT5-selective inhibitors suppress inflammatory T cell responses and experimental autoimmune encephalomyelitis LM Webb, SA Amici, KA Jablonski, H Savardekar, AR Panfil, L Li, W Zhou, ... The Journal of Immunology 198 (4), 1439-1451, 2017 | 69 | 2017 |
| Transcriptional impact of Aire varies with cell type M Guerau-de-Arellano, D Mathis, C Benoist Proceedings of the National Academy of Sciences 105 (37), 14011-14016, 2008 | 68 | 2008 |
| Chemokines and Toll-like receptors in Lyme disease pathogenesis M Guerau-de-Arellano, BT Huber Trends in molecular medicine 11 (3), 114-120, 2005 | 60 | 2005 |
| Salient type 1 interleukin 1 receptor expression in peripheral non-immune cells A Song, L Zhu, G Gorantla, O Berdysz, SA Amici, M Guerau-de-Arellano, ... Scientific reports 8 (1), 723, 2018 | 55 | 2018 |
Michael RackeProfessor of Neurology, Ohio State UniversityDirección de correo verificada de osumc.edu
